20 Years Of Helping Australians Make Better Decisions About Medicines, Medical Tests And Other Health Technologies.
Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.
You have not selected any filters.
Discuss your patients’ expectations of GORD management and assess their ongoing need for PPIs with the aim of stepping down treatment.
Update your knowledge about the stepwise approach to managing COPD, and review the range of medicines and devices currently used to treat COPD.
Update your knowledge about the range of glucose-lowering medicines available and their role in the treatment of type 2 diabetes.
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?
Optimise your patients’ adherence to lipid-modifying medicines and improve your confidence in assessing suspected statin-associated muscle symptoms.
How can you optimise a patient’s methotrexate therapy for the management of rheumatoid arthritis?
Optimal management of patients with rheumatoid arthritis depends on successful collaboration between rheumatologists, GPs and community pharmacists.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality for people with diabetes and the largest contributor to the direct and indirect costs of diabetes. Approximately 65% of all CVD deaths in Australia occur in people with diabetes or prediabetes.Over the last few years, the management of type 2 diabetes has rapidly grown more complex. Recent developments include new medicines, emerging clinical trial results that provide cardiovascular (CV) outcome data related to blood glucose-lowering medicines, and an update to clinical guidelines. Now, more than ever, a clear, stepped approach is necessary to navigate the plethora of options available and reduce risk of microvascular and macrovascular complications.This webinar has been developed in partnership with the Australian Diabetes Society.This program is funded by Boehringer Ingelheim Pty Limited and Eli Lilly Australia Pty Limited and managed through VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The program has been designed, developed and implemented by NPS MedicineWise with complete independence and editorial control and is based on best practice guidelines.
How do we optimise a patient’s statin therapy for the management of dyslipidaemia with minimal side effects?
Review your quality use of antidepressants with patients with depression.
Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury.Musa Drini, Aust Prescr 2017;40:91-3
A series of three modules to train prescribers and pharmacists on the use of the SafeScript system. The first module details the functionality of real-time prescription monitoring (RTPM) and its safety benefits. The second module has a focus on safe and appropriate dispensing of high-risk medicines, and managing concerns about patient safety regarding the use of high-risk medicines. The third module details best practice communication strategies to help prepare for conversations with patients about high-risk medicines.Although we recommend attempting these modules in sequential order, it is possible to complete the modules in any order and still earn the allocated CPD credit, provided you pass each assessment with a score of 80% or higher.Access is restricted to health practitioners in Victoria.
Penicillins and cephalosporins can cause a similar spectrum of allergic reactions at a similar rate. Cross-reactive allergy between penicillins and cephalosporins is rare, as is cross-reaction within the cephalosporin group. Patients should therefore not be labelled ‘cephalosporin-allergic’. Carlo L Yuson, Constance H Katelaris, William B Smith Aust Prescr 2018;41:37-41
Warfarin and the new oral anticoagulants are licensed for non-valvular atrial fibrillation and venous thromboembolism. The choice of anticoagulant depends on the characteristics of the patient and the medicine. Paul KL Chin, Aust Prescr 2016;39:200-4
The clinical diagnosis of heart failure should be confirmed by echocardiogram to determine the underlying mechanism and to measure the left ventricular ejection fraction. Ingrid Hopper and Kellie Easton Aust Prescr 2017;40:128-136
There are more than a dozen different inhaled medicines for COPD and multiple devices. How can you help your patients get the best out of theirs?
Naloxone is a competitive antagonist at opioid receptors. It can be administered to reverse the effects of an opioid overdose.In the face of increasing overdose deaths, from both prescription opioids and heroin, a wide range of people may benefit from increased access to naloxone. Marianne E Jauncey and Suzanne Nielsen Aust Prescr 2017;40:137-140
If there are no features of serious disease, suspected gastro-oesophageal reflux disease can be initially managed with a trial of a proton pump inhibitor for 4–8 weeks. This should be taken 30–60 minutes before food for optimal effect. Charlotte Keung and Geoffrey Hebbard, Aust Prescr 2016:39:6-10
This free course will guide you through the adverse event reporting process. Reporting adverse events is important to ensure that therapeutic products continue to be safe.
There are morbidity and mortality benefits for infants who are breastfed for longer periods. Occasionally, drugs are used to improve the milk supply.Maternal perception of an insufficient milk supply is the commonest reason for ceasing breastfeeding. Maternal stress or pain can also reduce milk supply.Treasure M McGuire Aust Prescr 2018;41:7-9
Patients may be susceptible to adverse drug events during acute illness due to comorbidities or medicine use. Acute illness should prompt careful monitoring or dose adjustment in patients prescribed certain medicines.Tom N Lea-Henry, Jonathan Baird-Gunning, Elizabeth Petzel, Darren M Roberts Aust Prescr 2017;40:168-73
Chronic hepatitis C infection causes cirrhosis, liver failure and hepatocellular carcinoma, and is the most common indication for liver transplantation. Hepatitis C is curable and complications can be prevented.Alex J Thompson and Jacinta A Holmes, Aust Prescr 2015;38:191-7
Most commonly used drugs are relatively safe for breastfed babies. The dose received via milk is generally small and much less than the known safe doses of the same drug given directly to neonates and infants.Neil Hotham and Elizabeth Hotham, Aust Prescr 2015;38:156-9
Persistent cigarette smokers usually have a nicotine addiction. This addiction has a chronic relapsing and sometimes remitting course and may persist lifelong. Mike McDonough, Aust Prescr 2015;38:106-11
Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves.Philip A Tideman, Rosy Tirimacco, Andrew St John, Gregory W RobertsAust Prescr 2015;38:44-8
Home blood pressure monitoring is the self-measurement of blood pressure by patients. In the diagnosis and management of high blood pressure it is complementary to 24-hour ambulatory blood pressure monitoring and clinic blood pressure measurements. Barry P McGrath, Aust Prescr 2015;38:16-9
The combined oral contraceptive pill is an effective contraceptive method which can also offer other benefits. However, other contraceptive options should be discussed. If the pill is the chosen method, prescribe a pill with the lowest effective dose of oestrogen and progestogen.Mary Stewart and Kirsten Black, Aust Prescr 2015;38:6-11
Patients receiving palliative care are at high risk of adverse effects from drugs. As these effects can be difficult to distinguish from the symptoms of the terminal illness, harm from medicines is often not recognised. Debra Rowett and David Currow, Aust Prescr 2014;37:204-9
Valproate is an anticonvulsant drug which is approved for use in epilepsy and bipolar disorder. It has also been used for neuropathic pain and migraine prophylaxis. Ahamed Zawab and John Carmody, Aust Prescr 2014;37:124-7
Efflux transporters such as P-glycoprotein play an important role in drug transport in many organs. In the gut, P-glycoprotein pumps drugs back into the lumen, decreasing their absorption. Andrew Finch and Peter Pillans, Aust Prescr 2014;37:137-9
Some nutrient supplements and herbal medicines have supportive evidence for efficacy in some mental health disorders, other products do not. Jerome Sarris, Aust Prescr 2014;37:90-3
Depression treatment should be tailored to the individual patient. Meet two different patients with depression. How would you progress their initial care?
Dose administration aids can improve medicines management for some people. However, they have a number of limitations and are not suitable for all patients. Rohan A Elliott, Aust Prescr 2014;37:46-50
Treat a hospitalised patient for a catheter-associated urinary tract infection.
A 4 year old diagnosed with asthma 6 months ago presents with worsening asthma symptoms. This free CPD activity is a case study on optimising asthma control in children.
This online learning module is centred around a video that guides clinicians on how to obtain and record a BPMH.
Explore common secondary causes of osteoporosis and how to prevent fractures with this free CPD case study from NPS.
RACF Medicinewise Reports can identify patterns of antibiotic use, support appropriate prescribing of antibiotics to treat urinary infections (UTIs) and prevent antibiotic resistance.
The majority of patients do not use their asthma inhaler device correctly - engage them with conversations and demonstations of correct technique.
This case study explores the diagnostic approach to managing urinary tract infections in residential aged care facility residents to reduce antibiotic resistance.
This interactive case study has been designed to help you improve accuracy in identifying elevated blood pressure in patients as well as better interpret the results of both in-clinic and out-of-clinic assessments.
Two different patients with type 2 diabetes. How would you manage their diabetes care? A free case study from NPS.
Diagnose and treat a case of community acquired pneumonia in a hospital setting.
This interactive module explores the diagnostic approach to fatigue in young to middle-aged adults, to improve your knowledge, skills and confidence in assessing patients with this condition.
This continuing professional development activity assists pharmacists and nurses to reflect on management of urinary tract infections (UTIs) and use of antibiotics.
Diagnosing causes of fatigue - meet Arya Saab, for the last two months she has been feeling tired and has asked for some tests to determine the cause of her fatigue.
Examine the role of antibiotic prophylaxis for patients undergoing surgical procedures.
This online learning module will provide you with an overview of the diagnostic approach to urinary tract infections in residents in aged-care facilities, consistent with the principles outlined in Therapeutic Guidelines: Antibiotic (Version 15).
Weigh up the need for antibiotics with two different cases of acute otitis media in this free CPD case study.
This course is designed to explore the various causes of medication errors and equip you with the knowledge and skills to help prevent errors from occurring in your workplace.
This module is designed to explain the role of bioequivalence in generic medicines development and to assist health professionals to feel confident explaining these principles to patients.
A 78-year old woman presents with worsening arthritic pain. What factors are contributing to her pain and what are the management options?
Learn the principles of safe prescribing and how to correctly complete the National Standard Medication Charts.
Improve your accuracy in identifying elevated blood pressure and better interpret the results of both in-clinic and out-of-clinic assessments within the context of absolute cardiovascular risk.
Watch an expert panel in discussion on new therapies, and how to identify and manage difficult-to-treat and severe asthma.This program is joint-funded by AstraZeneca Pty Ltd and Novartis Pharmaceuticals Australia Pty Ltd and managed by VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The content has been designed, developed and delivered by NPS MedicineWise with complete independence and editorial control, based on best practice guidelines.